Moderna, Inc. 4

Moderna CLO Shannon Thyme Klinger had 11,797 RSUs vest into common stock and 5,704 shares withheld for taxes, ending with 81,340 common shares and 106,179 RSUs.

On September 4, 2026, Moderna, Inc. Chief Legal Officer Shannon Thyme Klinger had 11,797 restricted stock units convert into common stock on a one-for-one basis, increasing her direct common stock holdings, and simultaneously had 5,704 shares withheld by the company at a price of $148.87 per share to cover tax obligations upon vesting; these are routine equity compensation and tax-withholding transactions rather than open-market purchases or discretionary sales. Following these transactions, she directly owned 81,340 shares of common stock and 106,179 restricted stock units, reflecting continued significant equity exposure to Moderna.

Filing Facts

CIK

1682852

Ticker

MRNA

Form

4

Source Type

fda

Accession

0001682852-26-000169

Alert Tier

7